The first genome-wide association study in individuals with European genetic ancestry has identified several chemokine receptor genes, including CCR9, CXCR6, and XCR1 and the locus controlling the ABO blood type to be associated with severe symptoms of COVID-19 (15). The gene discussed is ABO; the disease is COVID-19.